ArticleAIDS care2025
Perceptions about using a patient portal to self-disclose HIV-related information to sexual partners: a qualitative study among adolescents and emerging adults living with HIV.
Article in AIDS care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterizing HIV-related patient portal preferences among men who have sex with men in the United States.BMC public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Patient portals may enhance HIV viral load (VL) disclosure experiences between adolescents and emerging adults living with HIV (AHIV) and their partners. This qualitative inquiry investigated AHIV perspectives on using a patient portal to self-disclose HIV-related information to partners. 16 AHIV aged 13-25 years were recruited at a health center in the United States to participate in audio-recorded virtual in-depth interviews (IDIs). Participants discussed perspectives on HIV self-disclosure, facilitating self-disclosure processes using the patient portal, and what they wanted others to know about AHIV. Content analysis was conducted using combined deductive and inductive coding. Discussion topics were analyzed in the context of three emergent perspectives: (a) Sexually Naïve, (b) Approach-oriented, and (c) Disclosure Averse/Indifferent. Patient portals were perceived to offer unique advantages by providing a "receipt" for HIV VL and possessed key opportunities to educate partners about living with HIV, Undetectable=Untransmittable, and counter pervasive HIV myths. For some, the perceived negative consequences of HIV disclosure outweigh the potential benefits of leveraging the portal. AHIV support using portals to reverse the stigma anticipated with HIV self-disclosure. Research on practical and effective strategies for safely engaging in patient portal facilitated disclosures is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.